DOCSLIB.ORG

Electroconvulsive Therapy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Electroconvulsive Therapy Task Force Reports This is the fourteenth in a series of reports approved by the Board of Trustees of the American Psychiatric Association to give wider dissemination to the findings of APA's many commissions, committees, and task forces that are called upon to evaluate the state of the art in a problem area of current concern to the profession, to related disciplines, and to the public. The findings, opinions, and conclusions of the report do not necessarily represent the views of the officers, trustees, or all members of the Association. Each report, however, does represent the thoughtful judgment and findings of the task force of experts who composed it. These reports are considered a substantive contribution to the ongoing analysis and evaluation of problems, programs, issues, and practices in a given area of concern. Jules H. Masserman, M.D. President, APA, 1978-79 September 1978 Library of Congress Catalogue No. 78-69521 Copyright 1978 by the American Psychiatric Association 1700 18th Street, N.W., Washington, D.C. 20009 ELECTROCONVULSIVE THERAPY Report of the Task Force on Electroconvulsive Therapy of the American Psychiatric Association Fred H. Frankel, M.B.Ch.B., D.P.M. Chairperson T. George Bidder, M.D. Max Fink, M.D. Michel R. Mandel, M.D. Iver F. Small, M.D. George J. Wayne, Ph.D., M.D. Larry R. Squire, Ph.D., Consultant Edward N. Dutton, M.D., Falk Fellow Lee Gurel, Ph.D., Staff Liaison Approved for Publication by the Council on Research and Development Lester Grinspoon, M.D. Chairperson Edward Joel Sachar, M.D. Vice-Chairperson John M. Davis, M.D. Charles Gaitz, M.D. Frank DeLeon-Jones, M.D. Leigh Roberts, M.D., Assembly Liaison Louis Linn, M.D., Board Liaison Henry H. Work, M.D., Staff Liaison Publication authorized by the Board of Trustees May 1978 AMERICAN PSYCHIATRIC ASSOCIATION 1700 18th Street, N.W. Washington, D.C. 20009 THE AUTHORS and TASK FORCE MEMBERS Fred H. Frankel, M.B.Ch.B., D.P.M. Chairperson Department of Psychiatry, Beth Israel Hospital and Harvard Medical School, Boston, Mass. T. George Bidder, M.D. Department of Psychiatry, UCLA School of Medicine and Sepulveda VA Hospital, Los Angeles, Calif. Max Fink, M.D. Department of Psychiatry and Behavioral Science, School of Medicine, State University of New York at Stony Brook Michel R. Mandel, M.D. Department of Psychiatry, Massachusetts General Hospital and Har- vard Medical School, Boston, Mass. Iver F. Small, M.D. Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana George J. Wayne, Ph.D., M.D. Department of Psychiatry, UCLA School of Medicine and Edgemont Hospital, Los Angeles, Calif. Larry R. Squire, Ph.D. Consultant Veterans Administration Hospital, San Diego, Calif. Department of Psychiatry, University of California, San Diego, at La Jolla, Calif. Edward N. Dutton, M.D. Falk Fellow Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio Lee Gurel, Ph.D., Staff Liaison American Psychiatric Association ii ACKNOWLEDGEMENTS The Task Force gratefully acknowledges the advice, assistance, con- sultation and contributions of the following: Gregory Asnis, M.D. H. Richard Beresford, M.D. David Boehm, B.A. Rosmary Krispinsky Cheesman, R.N. N. Jeanne Cooper, L.P.N. Jane E. Edgerton Theodore W. Lorei, M.S.W. Doris T. Pearsall, M.A. Psychotherapy Institute and Continuing Education Program, Psychiatry Service, Beth Israel Hospital, Boston Loren H. Roth, M.D., Member of the Commission on Judicial Action, APA Sue Saferstein, B.A. Sibley Memorial Hospital, Washington, D.C. Pam C. Slater Era Smith Caroline Starcher, R.N. Alan A. Stone, M.D. Chairperson, Commission on Judicial Action, APA James J. Strain, M.D. Zebulon Taintor, M.D. Ann Tom, B.A. Richard D. Weiner, M.D., Ph.D. The members of the A.P.A. who responded to the Questionnaire; and those who addressed the Hearings in Miami, May, 1976 These contributions were aided, in part, by grants MH-15561, 20872, and 24600 from the National Institute of Mental Health; by the International Association for Psychiatric Research, Inc; by Veterans Administration Clinical Inves- tigatorship 808 4C. iii This page intentionally left blank CONTENTS Introduction .................................... vii Chapter I. A Survey of the APA Membership on the Use of ECT .......................... 1 Chapter II. Efficacy in Affective Disorders and Schizo- phrenia' .......................... 13 Chapter III. ECT in Mental Illness other than Schizo- prenia and the Affective Disorders ........ 31 Chapter IV. Adverse Effects of ECT .............. 57 Section I. Memory and ECT ........ 57 Section II. CNS Sequelae of ECT: Risks of Therapy and their Prophylaxis ............... 72 Section III. ECT: Possible Neurological Side-effects .............. 87 Chapter V. ECT: Methods of Administration .......... 92 Chapter VI. Physiological and Biochemical Concomitants of ECT .......................... 122 Chapter VII. Social, Ethical, and Legal Aspects of ECT . 132 Chapter VIII. Training and Education .............. 151 Chapter IX. Future Research ................... 157 Chapter X. Recommendations Regarding the Use of ECT ........................... 161 Appendices Description of ECT for Informed Consent . 174 APA Questionnaire .................. 179 v This page intentionally left blank INTRODUCTION This report on Electroconvulsive Therapy contains few simple solu- tions. We will be pleased if it helps to lead to a rational perspective. An examination of the published literature since the early 1940s reveals the mixed reception accorded ECT since its introduction in 1938. Attitudes surrounding it capture the essence of the struggle between the rival philosophical approaches to emotional and mental illness, namely the psychological, the biological, and the social. We believe that what follows in this report affirms that the last word has yet to be written on the etiology and treatment of psychiatric illness, as well as on the most useful role for government and the courts in attempting to prevent or manage it. Those who disagree have misled us in the past by exaggerating a single viewpoint; they will no doubt attempt to do so again. In the fall of 1974, the Council on Research and Development resolved to establish a task force on ECT "with tenure of about two years, to have liaison with the Commission on Judicial Action and to include in its study consideration of legislative issues, consent, indications for its use and possible increasing use because of short- ened length of stay in hospital." The Task Force assembled for the first time in September 1975, with the following mandate approved by the Council: Mandate to the APA Task Force on ECT The task force is enjoined to: (1) Review the current use of ECT, both typical and atypical, the prevailing criticisms of its use, and the recent and current research on the subject with special but not exclusive refer- ence to studies of: (a) its indications in different clinical entities; (b) its benefits in relation to its adverse effects; (c) treatment techniques designed to minimize adverse ef- fects, particularly memory loss and confusion; (d) the effectiveness of associated drug therapy; (e) associated neurochemical and neurophysiological changes; (f) long term effects, both beneficial and adverse; (g) comparisons with other treatment methods; vii Task Force Report 14 (h) comparable treatments with flurothyl; (i) associated cerebral and behavioral events; (j) induced seizures and convulsive shock in animals. (2) Report its conclusions regarding the benefits of ECT in relation to the risks involved. (3) Describe the indications for its use and the contraindications. (4) Make recommendations regarding: (a) general clinical considerations; (b) pretreatment investigations and precautions; (c) the use of anesthesia and related measures to reduce the dangers of treatment; (d) techniques with reference to apparatus, schedules of administration including those of multiple and single treatments, appropriate numbers of treatments, location of electrodes, and after-care procedures; (e) the simultaneous use of drug therapy; (f) criteria of improvement and indications for the termina- tion of treatment. (5) Consider the civil liberties of patients and informed consent in the management of treatment programs. (6) Comment and advise on related legislative issues. (7) Recommend directions for future research and study. (8) Report on any other issues it considers relevant. In all, the Task Force held five two-day meetings through the two years, as well as an evening meeting and a two-day open forum at the time of the annual meeting in Miami in 1976. Because the published literature, although considerably more helpful in recent years than previously, still provides only a limited number of well controlled studies, it was thought essential that the empirical evidence available be evaluated and given serious con- sideration. The members therefore decided on exploring four main avenues in order to accumulate the information needed by them to discharge their mandate. The methods selected were: (1) a search of the literature; (2) a national survey of a 20% random sample of the approxi- mately 20,000 APA members to provide data on the extent of the use of ECT, the indications for its use, the methods and techniques in general use, and the general experience of its viii ELECTROCONVULSIVE THERAPY effectiveness; these data were to provide the context within which to consider the questions raised in the mandate; (3) an open forum for the discussion of ECT at the annual meeting in 1976. As not more than 20% of the membership would be polled in the national survey, an opportunity was to be provided for members generally to report on their views and experience to the members of the Task Force if they so wished. Announcements in Psychiatric News extended an invitation to the membership to arrange for an appointed time at which they could address the Task Force. Twenty four individuals had an opportunity to communicate personally in this way with the committee. Invitations were extended to a few highly experienced clinicians to share their views with us, as well as to two colleagues in neurology known to hold strong views against the use of ECT.
Load more

Recommended publications
  • ABSTRACT Autism Spectrum Disorder (ASD)
    ADLN - Perpustakaan Universitas Airlangga ABSTRACT Autism Spectrum Disorder (ASD) was a disturbance of pervasife development in children characterized by the disturbance and delayed in cognitive, language, behaviour, communication, and social interaction. In the past 10 to 20 years, increased the number of autism currently reached an average of 8 persons among 1000 resident or 1:125. The cause of autism is is yet not found until now. The purpose of this research is analize risk factor of the trigger autism in children. This research used case control design. In the case category (ASD) accounted for 35 children according to record data in special school and the control category as many as 105 children taken from public school. Independent variables were genetic, premature, postmature, antenatal bleeding, maternal age of pregnancy, caesar childbirth, low birth weight (LBW), interval of pregnancy, organic brain syndrome, asphyxia, vaccination, smoking, consumtion of medicine and medicinal herbs, and spontaneous abortion. Whereas dependent variable was ASD incident. The data analysis by calculated odds ratio with 95% CI. The result of the research obtained were genetic, postmature, antenatal bleeding, caesar childbirth, low birth weight, interval of pregnancy, organic brain syndrome, asphyxia, vaccination, smoking, consumtion of medicine and medicinal herbs, spontaneous abortion was not the risk factor of the trigger ASD incident. The result obtained on the variables that significally premature (OR= 7.12 , 95% CI: 2.56<OR<26.07) which means that the children born prematurely had a 7.12 times higher for the onset of autism than children born with normal gestational age and another variable maternal age over 35 years (OR=8.58 , 95% CI: 1.30 <OR< 92.57) which means that the mother was pregnant at the age over 35 years had a 5.58 times higher risk to had children had autism than the mother who become pregnant less than 35 years.
    [Show full text]
  • Curriculum Vitae Peter Robert Martin Address
    CURRICULUM VITAE PETER ROBERT MARTIN ADDRESS: Department of Psychiatry and Behavioral Sciences Vanderbilt Psychiatric Hospital Suite 3035, 1601 23rd Avenue South Nashville, Tennessee 37232-8650 U.S.A. Phone: 615-343-4527 Mobile: 615-364-7175 E-Mail: [email protected] [email protected] https://orcid.org/0000-0003-2292-4741 WEBSITES: https://wag.app.vanderbilt.edu/PublicPage/Faculty/Details/27348 http://www.vanderbilt.edu/ics/ DATE AND PLACE OF BIRTH: September 6, 1949, Budapest, Hungary FAMILY: Married Barbara Ruth Bradford, December 23, 1985 Alexander Bradford Martin, born October 21, 1989 EDUCATION: 1967 - 1971 Honours B.Sc. (Molecular Genetics) McGill University, Montreal, Quebec, Canada 1971 - 1975 M.D., C.M. McGill University, Montreal, Quebec, Canada 1975 - 1976 Resident in Internal Medicine, Sunnybrook Medical Centre, University of Toronto, Toronto, Ontario, Canada 1976 - 1978 Research Fellow in Clinical Pharmacology, Clinical Pharmacology Program, Addiction Research Foundation Clinical Institute - Toronto Western Hospital, University of Toronto 1976 - 1979 M.Sc. (Pharmacology) University of Toronto Dissertation: Intravenous phenobarbital treatment of barbiturate and other hypnosedative withdrawal: A pharmacokinetic approach. 1978 - 1979 Resident in Psychiatry, Affective Disorders Unit, Clarke Institute of Psychiatry, University of Toronto 1979 Resident in Psychiatry, Hospital for Sick Children, University of Toronto 1980 Resident in Psychiatry, Toronto General Hospital, University of Toronto LICENSURE AND CERTIFICATION: The College of Physicians and Surgeons of Ontario (License No. 28907), 1976. The Board of Medical Examiners of the State of Maryland (License No. D26685), 1981. The Board of Medical Examiners of the State of Tennessee (License No. MD17128), 1986. Fellow of the Royal College of Physicians (Canada), Psychiatry, 1981.
    [Show full text]
  • PAVOL JOZEF ŠAFARIK UNIVERSITY in KOŠICE Dissociative Amnesia: a Clinical and Theoretical Reconsideration DEGREE THESIS
    PAVOL JOZEF ŠAFARIK UNIVERSITY IN KOŠICE FACULTY OF MEDICINE Dissociative amnesia: a clinical and theoretical reconsideration Paulo Alexandre Rocha Simão DEGREE THESIS Košice 2017 PAVOL JOZEF ŠAFARIK UNIVERSITY IN KOŠICE FACULTY OF MEDICINE FIRST DEPARTMENT OF PSYCHIATRY Dissociative amnesia: a clinical and theoretical reconsideration Paulo Alexandre Rocha Simão DEGREE THESIS Thesis supervisor: Mgr. MUDr. Jozef Dragašek, PhD., MHA Košice 2017 Analytical sheet Author Paulo Alexandre Rocha Simão Thesis title Dissociative amnesia: a clinical and theoretical reconsideration Language of the thesis English Type of thesis Degree thesis Number of pages 89 Academic degree M.D. University Pavol Jozef Šafárik University in Košice Faculty Faculty of Medicine Department/Institute Department of Psychiatry Study branch General Medicine Study programme General Medicine City Košice Thesis supervisor Mgr. MUDr. Jozef Dragašek, PhD., MHA Date of submission 06/2017 Date of defence 09/2017 Key words Dissociative amnesia, dissociative fugue, dissociative identity disorder Thesis title in the Disociatívna amnézia: klinické a teoretické prehodnotenie Slovak language Key words in the Disociatívna amnézia, disociatívna fuga, disociatívna porucha identity Slovak language Abstract in the English language Dissociative amnesia is a one of the most intriguing, misdiagnosed conditions in the psychiatric world. Dissociative amnesia is related to other dissociative disorders, such as dissociative identity disorder and dissociative fugue. Its clinical features are known
    [Show full text]
  • Social Cognition in Eating Disorders: Encoding and Representational Processes in Binging and Purging Patients
    RESEARCH ARTICLE Social Cognition in Eating Disorders: Encoding and Representational Processes in Binging and Purging Patients Lily Rothschild-Yakar1,2*, Zohar Eviatar2, Adi Shamia2 & Eitan Gur3 1Safra Children’s Hospital, Sheba Medical Center, Tel Hashomer, Israel 2Department of Psychology, University of Haifa, Israel 3Sheba Medical Center, Tel Hashomer, Israel Abstract Objective: The present study investigates social cognition impairments in 29 women with bingeing/purging spectrum eating disorders (ED) compared to 27 healthy controls. Method: Measures were used to examine encoding and representational processes in relation to affect perception and affect attribution, as well as the ability to recognize mental causality in social relationships. Results: ED patients failed to correctly encode causality in interpersonal relations, exhibited deficits in their ability to ascribe behaviour to mental states, and showed a greater tendency to attribute negative affects in interpersonal relationships. Stepwise regression analyses suggested that ED symptoms could account for deficits in the recognition of causality in interpersonal relations. Conclusions: In addition to addressing ED symptoms, social cognition deficits should be addressed in the psychological treatment of EDs. Copyright # 2010 John Wiley & Sons, Ltd and Eating Disorders Association. Keywords eating disorders; social cognition; mentalization *Correspondence Lily Rothschild-Yakar, PhD, Department of Psychology, University of Haifa, Haifa 31905, Israel. Tel: 972-3-649-9563; Fax: 974-4-824-0966. Email: [email protected] Published online 29 July 2010 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/erv.1013 cognition in AN (restricting type), suggesting similarities Introduction with autistic spectrum disorders. They suggested that Dysfunctional social cognition may play an important deficits in social cognition may be central to the role in eating disorders (ED).
    [Show full text]
  • Catatonia and Melancholia
    Department of Psychiatry Columbia University, College of P&S NYS Psychiatric Institute DDIIVVIISSIIOONN OOFF BBRRAAIINN SSTTIIMMUULLAATTIIOONN AANNDD TTHHEERRAAPPEEUUTTIICC MMOODDUULLAATTIIOONN SSPPEECCIIAALL LLEECCTTUURREE MMaaxx FFiinnkk,, MM..DD.. PPrrooffeessssoorr ooff PPssyycchhiiiaattrryy aanndd NNeeuurroollooggyy EEmmeerriiittuuss SSUUNNYY,,, SSttoonnyy BBrrooookk CCaattaattoonniiaa aanndd MMeellaanncchhoolliiaa:: RReessppoonnssiivvee ssyynnddrroommeess Wednesday October 22, 2008 12:00 PM to 1:00 PM Location: New York State Psychiatric Institute, 1051 Riverside Drive, Rm. 6601 (Board Room) (Enter Kolb Annex, 40 Haven Ave., turn rt., walk though atrium, across bridge over Riverside Dr. to new NYSPI, walk south along main corridor) (See over for speaker brief biography and J Club paper) About Max Fink, M.D. Dr. Max Fink is one of the world’s leading experts in Electroconvulsive Therapy (ECT). Since 1972, he has been at SUNY at Stony Brook, where he is Professor of Psychiatry and Neurology Emeritus. Since 1997, he has also been on the faculty at AECOM and the LIJ-Hillside Medical Center. Dr. Fink's studies of ECT began at Hillside Hospital in 1952, and he has published broadly on predictors of outcome in ECT, effects of seizures on EEG and speech, hypotheses of the mode of action, and how to achieve an effective treatment. In 1972, with Drs. Seymour Kety and James McGaugh, he organized an NIMH sponsored conference on the biology of convulsive therapy which resulted in the volume Psychobiology of Convulsive Therapy (1974). In 1979, he published the textbook Convulsive Therapy: Theory and Practice (Raven Press, 306 pp.). In 1984, he established CONVULSIVE THERAPY, a quarterly scientific journal (renamed Journal of ECT). From 1975 to 1978, and again from 1987 to 1990, he was a member of the Task Forces on Electroconvulsive Therapy of the American Psychiatric Association.
    [Show full text]
  • Amnesia: Its Detection by Psychophysiological Measures
    Amnesia: Its Detection by Psychophysiological Measures BRIAN E. LYNCH, M.A.* and JOHN McD. W. BRADFORD, M.B., Ch.B. (VCT), D.P.M. (VCT), F.F. PSYCH. (SA), M.R.C. P S Y C H. ( V . K . ) ** Introduction The term amnesia encompasses many varied examples and causes of memory loss. In an edited text on amnesia, Whitty and Zangwill explore the subject in terms of cerebral disease, trauma, electroconvulsive therapy and psychogenesis. 1 It becomes obvious from the various causative factors involved in amnesia that such a multi-factorial problem requires an eclectic approach in answering. At present, one area being investigated in some detail is alcohoVdrug-induced memory loss. The focus of the present study is the exploration of memory dysfunction resulting from alcohoVdrug abuse. In any discussion of alcohoVdrug-induced amnesia certain features of the dysfunction become important for consideration. Before the amnesia can be examined it must be determined to be either a legitimate loss or a feigned amnesia state. The basis of feigned versus genuine amnesia rests with an individual's biological and psychological resources. Expediency suggests that genuine amnesia tends toward an organic base and feigned toward a psychogenic base. That is to say, the probability of a genuine amnesia is greatly increased when found in concert with organicity. Likewise, feigned memory loss is more likely to be found in individuals suffering from a psychogenic disorder. In addition to the issue of genuine versus feigned amnesia, the type of memory loss is important in any clinical assessment of the disorder. The present study utilizes a clinical breakdown of amnesia type in accordance with characteristics outlined by Bradford and Smith.2 The amnesia states are discussed in relation to the following category types: (A) hazy amnesia: no absolute amnesia either in circumscribed periods or in one complete period; (B) partial (patchy) amnesia: segments of memory loss with no complete period of amnesia; (C) complete amnesia: total ·Mr.
    [Show full text]
  • Madness As Disability
    HPY0010.1177/0957154X14545846History of PsychiatryGilman 545846research-article2014 Article History of Psychiatry 2014, Vol. 25(4) 441 –449 Madness as disability © The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/0957154X14545846 hpy.sagepub.com Sander L Gilman Emory University, Atlanta, USA Abstract How does society imagine mental illness? Does this shift radically over time and with different social attitudes as well as scientific discoveries about the origins and meanings of mental illness? What happens when we begin to think about mental illness as madness, as a malleable concept constantly shifting its meaning? We thus look at the meanings associated with ‘general paralysis of the insane’ in the nineteenth century and autism today in regard to disability. In this case study we examine the claims by scholars such as the anthropologist Emily Martin and the psychiatrist Kay Jamison as to the relationship between mental illness, disability and creativity. Today, the health sciences have become concerned with mental illness as a form of disability. How does this change the meaning of madness for practitioners and patients? Keywords Autism, bipolar disease, disability, madness With interest in mental illness from the standpoint of the growing field of disability studies comes a problem for the medical humanities (Callard et al., 2012; Longmore and Umansky, 2001). Is it possible to discuss what may well be the most stigmatizing form of illness or disability in the West without understanding the complexity of the tradition in which it stands? The diagnostic history of mental illness is entangled with the history of madness as a social convention, a history that colours even the contemporary debates about the meanings and forms of mental illness in our age of brain imagery and neuro-anatomy.
    [Show full text]
  • Delirium & Delirious Mania
    Delirium & Delirious Mania; Differential Diagnosis. Delirium & Delirious Mania; Differential Diagnosis. Author: Eline Janszen. (s894226) Thesis-Supervisor: Ruth Mark Bachelorthesis Clinical Health Psychology Department of Neuropsychology, University of Tilburg September, 2011. 1 Delirium & Delirious Mania; Differential Diagnosis. ABSTRACT In the last few years, delirium in hospitals and in the elderly population has become an important subject of various studies, resulting in the recognition of several subtypes; hyperactive delirium, hypoactive delirium and mixed delirium. The first one of these subtypes, hyperactive delirium, shows a lot of overlap with another syndrome: Delirious mania. The current literature review examines both syndromes, discussing the overlap and the differences of their symptoms, while also looking at the neurological structures involved. Search engines including Sciencedirect, PSYCHinfo and medline were used to find the relevant literature. The data found in this examination reveals that, in spite of the several overlapping symptoms, delirious mania and hyperactive delirium are different syndromes; hyperactive delirium is associated with symptoms like hyperactivity, circardian rhythm disturbances and neurological abnormalities that include lesions of the hippocampus and dysfunction of the orbitofrontal cortex while delirious mania shows distinctive symptoms like pouring water and denudativeness (disrobing) with neurological abnormalities that also include orbitofrontal cortex dysfunction, but suffer mostly from an overall frontal circuitry dysfunction. This distinction is important for clinical outcome, seeing as that hyperactive delirium is treated with haloperidol and the preferred treatment for delirious mania is ECT. Keywords: delirium, hyperactive delirium, delirious mania. 2 Delirium & Delirious Mania; Differential Diagnosis. INTRODUCTION In recent years there has been a lot of research focused on diagnosing delirium. Since patients with delirium display fluctuating symptoms, the distinction from other conditions can be difficult.
    [Show full text]
  • Clinical Practice Guidelines for the BC Eating Disorders Continuum of Services September 1, 2012
    CLINICAL PRACTICE GUIDELINES for the BC EATING DISORDERS CONTINUUM OF SERVICES SEPTEMBER 1, 2012 < ONLY REVERSE OUT OF PHC BLUE, BLACK AND PHC OCHRE Ministry of Health (Project Leader) Gerrit van der Leer, MSW, Director, Mental Health and Addictions Authors Josie Geller, PhD, R. Psych, Director of Research, Eating Disorders Program, Providence Health Care. Associate Professor, Department of Psychiatry, University of British Columbia. Shawna Goodrich, MSW, Former Clinical Director, Eating Disorders Program, Providence Health Care Kathy Chan, MA, Graduate Student, University of Ottawa Sarah Cockell, PhD, R. Psych, Psychologist, Heart Centre, Providence Health Care Suja Srikameswaran, PhD., R. Psych, Professional Practice Leader, Psychology, Providence Health Care, Outpatient Psychologist, Eating Disorders Program, SPH, Clinical Associate Professor, Department of Psychiatry, University of British Columbia Provincial Advisory Committee Connie Coniglio, EdD, Clinical Director, Provincial Specialized Eating Disorder Program for Children and Adolescents, BC Children’s Hospital. Pei Yoong Lam, MD, FRACP, Assistant Clinical professor, Division of Adolescent Medicine, Department of Pediatrics, University of BC. Provincial Specialized Eating Disorders Program for Children and Adolescents, BC Children’s Hospital. Kim Williams, RD, Dietician, Eating Disorders Program, Providence Health Care Randy Murray, Practice Lead, Mental Health and Substance Use, Interior Health Shelagh Bouttell, MSc RD, Nutrition Therapist, Fraser South Eating Disorder Program,
    [Show full text]
  • HB-05298 Mendelsohn, Stephen
    Stephen Mendelsohn 171 Hartford Road, #19 New Britain, CT 06053-1532 [email protected] Testimony in support of HB 5298, An Act Concerning Involuntary Shock Therapy Senator Gerratana, Rep. Johnson, and members of the Public Health Committee: As a psychiatric survivor and member of Second Thoughts Connecticut, I strongly support HB 5298, An Act Concerning Involuntary Shock Therapy. This bill seeks to protect the right of people to say no to electroshock, a controversial and brain-disabling psychiatric intervention. While I have never had electroshock or insulin coma, being mislabeled "paranoid schizophrenic" and coerced into taking disabling neuroleptic drugs was horrible enough. HB 5298 is a modest bill. It does not ban electroshock, as the voters of Berkeley, CA did in a 1982 ballot referendum that passed with nearly 62% of the vote. The National Council on Disability, which Cathy Ludlum will cite in her testimony, has also taken a position against electroshock as a treatment modality (in addition to opposing forced treatment generally). According to an NCD report, "Public policy should move toward the elimination of electroconvulsive therapy and psychosurgery as unproven and inherently inhumane procedures." What we should strive for is fully informed, uncoerced consent. Unfortunately, institutional psychiatry is riddled with force, coercion, and deception, making truly informed consent difficult, if not nearly impossible. One cannot give informed consent to ECT if one is being threatened with involuntary commitment or forced drugging for refusing to sign the consent form. I would therefore urge you to consider strengthening this legislation by requiring "written informed, uncoerced consent" in section 17a-543 of the Connecticut General Statutes.
    [Show full text]
  • MILD TRAUMATIC BRAIN INJURY(Mtbi) TOPIC REPORT
    MILD TRAUMATIC BRAIN INJURY(mTBI) TOPIC REPORT An Updated Review Independent Medical Expert Group th 19 February 2021 1 Contents Key Points ............................................................................................................................................................................ 3 Introduction ......................................................................................................................................................................... 5 mTBI in Military Populations ........................................................................................................................................... 7 Early Predictors of Persistent Post-Concussion Symptoms ................................................................................. 8 Biomarkers .......................................................................................................................................................................... 9 Neuroimaging ..................................................................................................................................................................... 9 Magnetic Resonance Diffusion Tensor Imaging in mTBI .................................................................................... 9 Positron Emission Tomography .............................................................................................................................. 11 MEG: Basic Considerations .....................................................................................................................................
    [Show full text]
  • The Effect of Epilepsy on Autistic Symptom Severity Assessed by The
    Ko et al. Behav Brain Funct (2016) 12:20 DOI 10.1186/s12993-016-0105-0 Behavioral and Brain Functions RESEARCH Open Access The effect of epilepsy on autistic symptom severity assessed by the social responsiveness scale in children with autism spectrum disorder Chanyoung Ko1, Namwook Kim2,3, Eunjoo Kim4, Dong Ho Song2,3 and Keun‑Ah Cheon2,3* Abstract Background: As the prevalence of autism spectrum disorders in people with epilepsy ranges from 15 to 47 % (Clarke et al. in Epilepsia 46:1970–1977, 2005), it is speculated that there is a special relationship between the two disorders, yet there has been a lack of systematic studies comparing the behavioral phenotype between autistic individuals and autistic individuals with epilepsy. This study aims to investigate how the co-occurrence of epilepsy and Autism Spec‑ trum Disorder (ASD) affects autistic characteristics assessed by the Social Responsiveness Scale (SRS), which has been used as a measure of autism symptoms in previous studies. In this research we referred to all individuals with Autism or Autistic Disorder as individuals with ASD. Methods: We reviewed the complete medical records of 182 participants who presented to a single tertiary care refer‑ ral center from January 1, 2013 to July 28, 2015, and subsequently received complete child and adolescent psychiatric assessments. Of the 182 participants, 22 were diagnosed with Autism Spectrum Disorder and epilepsy. Types of epilepsy observed in these individuals included complex partial seizure, generalized tonic–clonic seizure, or infantile spasm. Using ‘Propensity Score Matching’ we selected 44 children, diagnosed with only Autism Spectrum Disorder, whose age, gender, and intelligence quotient (IQ) were closely matched with the 22 children diagnosed with Autism Spectrum Disorder and epilepsy.
    [Show full text]